Novavax: Large Study Finds COVID-19 Shot About 90% Effective

While demand for COVID-19 shots in the U.S. has dropped off dramatically, the need for more vaccines around the world remains critical.

  • Published
FILE - In this Wednesday, Oct. 7, 2020, file photo, a vial of the Phase 3 Novavax coronavirus vaccine is seen ready for use in the trial at St. George's University hospital in London. Novavax says its vaccine appears effective against COVID-19 in a large study, including against variants. Results from the study in the U.S. and Mexico were released on Monday, June 14, 2021. (AP Photo/Alastair Grant, File)
Image via AP Photo/Alastair Grant

This article was republished here with permission from The Associated Press, however it is no longer available to read on Snopes.com.

Vaccine maker Novavax said Monday its shot was highly effective against COVID-19 and also protected against variants in a large, late-stage study in the U.S. and Mexico. The vaccine was about 90% effective overall and preliminary data showed it was safe, the company said. While demand for COVID-19 shots in the U.S. has dropped off dramatically, the need for more vaccines around the world remains critical. The Novavax vaccine, which is easy to store and…

Read at AP News